Early Detection and Prognostic Assessment of Cutaneous Melanoma
JAMA Dermatology · 01.05.2023 · 159 (5) · 545
DOI: 10.1001/jamadermatol.2023.0127 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.05.2023. Verfasst von Mohammed Kashani-Sabet und 42 weiteren Autor:innen. Beteiligte Einrichtung: Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco. Hauptthemen laut MEDLINE: Skin Neoplasms, Melanoma. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Importance Therapy for advanced melanoma has transformed during the past decade, but early detection and prognostic assessment of cutaneous melanoma (CM) remain paramount goals. Best practices for screening and use of pigmented lesion evaluation tools and gene expression profile (GEP) testing in CM remain to be defined.
Objective
To provide consensus recommendations on optimal screening practices and prebiopsy diagnostic, postbiopsy diagnostic, and prognostic assessment of CM. Evidence Review Case scenarios were interrogated using a modified Delphi consensus method. Melanoma panelists (n = 60) were invited to vote on hypothetical scenarios via an emailed survey (n = 42), which was followed by a consensus conference (n = 51) that reviewed the literature and the rationale for survey answers. Panelists participated in a follow-up survey for final recommendations on the scenarios (n = 45).
Findings
The panelists reached consensus (≥70% agreement) in supporting a risk-stratified approach to melanoma screening in clinical settings and public screening events, screening personnel recommendations (self/partner, primary care provider, general dermatologist, and pigmented lesion expert), screening intervals, and acceptable appointment wait times. Participants also reached consensus that visual and dermoscopic examination are sufficient for evaluation and follow-up of melanocytic skin lesions deemed innocuous. The panelists reached consensus on interpreting reflectance confocal microscopy and some but not all results from epidermal tape stripping, but they did not reach consensus on use of certain pigmented lesion evaluation tools, such as electrical impedance spectroscopy. Regarding GEP scores, the panelists reached consensus that a low-risk prognostic GEP score should not outweigh concerning histologic features when selecting patients to undergo sentinel lymph node biopsy but did not reach consensus on imaging recommendations in the setting of a high-risk prognostic GEP score and low-risk histology and/or negative nodal status. Conclusions and Relevance For this consensus statement, panelists reached consensus on aspects of a risk-stratified approach to melanoma screening and follow-up as well as use of visual examination and dermoscopy. These findings support a practical approach to diagnosing and evaluating CM. Panelists did not reach consensus on a clearly defined role for GEP testing in clinical decision-making, citing the need for additional studies to establish the clinical use of existing GEP assays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco.
- Departments of Dermatology and Family Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland.
- Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, New York.
- Department of Dermatology, Emory University School of Medicine, Winship Cancer Institute, Atlanta Veterans Administration Health Center, Atlanta, Georgia.
- UA Cancer Center Skin Cancer Institute, Division of Dermatology, College of Medicine, University of Arizona, Tucson.
- Departments of Dermatology and Medicine, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
Förderung
- NCI NIH HHS
Zitieren
APA
Kashani-Sabet, M., Leachman, S. A., Stein, J. A., Arbiser, J. L., Berry, E. G., Celebi, J. T., Curiel-Lewandrowski, C., Ferris, L. K., Grant-Kels, J. M., Grossman, D., Kulkarni, R. P., Marchetti, M. A., Nelson, K. C., Polsky, D., Seiverling, E. V., Swetter, S. M., Tsao, H., Verdieck-Devlaeminck, A., Wei, M. L., …, & Kirkwood, J. M. (2023). Early Detection and Prognostic Assessment of Cutaneous Melanoma. JAMA Dermatology, 159(5), 545. https://doi.org/10.1001/jamadermatol.2023.0127
Vancouver
Kashani-Sabet M, Leachman SA, Stein JA, Arbiser JL, Berry EG, Celebi JT, et al. Early Detection and Prognostic Assessment of Cutaneous Melanoma. JAMA Dermatology. 2023;159(5):545. doi:10.1001/jamadermatol.2023.0127
BibTeX
@article{KashaniSabet2023,
author = {Kashani-Sabet, Mohammed and Leachman, Sancy A and Stein, Jennifer A and Arbiser, Jack L and Berry, Elizabeth G and Celebi, Julide T and Curiel-Lewandrowski, Clara and Ferris, Laura K and Grant-Kels, Jane M and Grossman, Douglas and Kulkarni, Rajan P and Marchetti, Michael A and Nelson, Kelly C and Polsky, David and Seiverling, Elizabeth V and Swetter, Susan M and Tsao, Hensin and Verdieck-Devlaeminck, Alexandra and Wei, Maria L and Bar, Anna and Bartlett, Edmund K and Bolognia, Jean L and Bowles, Tawnya L and Cha, Kelly B and Chu, Emily Y and Hartman, Rebecca I and Hawryluk, Elena B and Jampel, Risa M and Karapetyan, Lilit and Kheterpal, Meenal and Lawson, David H and Leming, Philip D and Liebman, Tracey N and Ming, Michael E and Sahni, Debjani and Savory, Stephanie A and Shaikh, Saba S and Sober, Arthur J and Sondak, Vernon K and Spaccarelli, Natalie and Usatine, Richard P and Venna, Suraj and Kirkwood, John M},
title = {Early Detection and Prognostic Assessment of Cutaneous Melanoma},
journal = {JAMA Dermatology},
year = {2023},
volume = {159},
number = {5},
pages = {545},
doi = {10.1001/jamadermatol.2023.0127}
}
EUVIMED